alternate Mediterranean Diet
Related entities
Findings (27)
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude
None
improvementMultiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier
Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude